As of 2025-07-04, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (19.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.13 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -476.9%.
The range of the Relative Valuation is (14.81) - (26.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 18.7x | 13.1x |
| Forward P/E multiples | 10.3x - 21.3x | 13.7x |
| Fair Price | (14.81) - (26.93) | (19.34) |
| Upside | -388.6% - -624.9% | -476.9% |
| Date | P/E |
| 2025-07-02 | -3.37 |
| 2025-07-01 | -3.37 |
| 2025-06-30 | -3.26 |
| 2025-06-27 | -3.35 |
| 2025-06-26 | -3.37 |
| 2025-06-25 | -3.40 |
| 2025-06-24 | -3.37 |
| 2025-06-23 | -3.39 |
| 2025-06-20 | -3.27 |
| 2025-06-18 | -3.29 |
| 2025-06-17 | -3.32 |
| 2025-06-16 | -3.04 |
| 2025-06-13 | -2.99 |
| 2025-06-12 | -3.15 |
| 2025-06-11 | -3.17 |
| 2025-06-10 | -3.21 |
| 2025-06-09 | -3.18 |
| 2025-06-06 | -3.09 |
| 2025-06-05 | -2.85 |
| 2025-06-04 | -2.91 |
| 2025-06-03 | -3.02 |
| 2025-06-02 | -2.89 |
| 2025-05-30 | -2.83 |
| 2025-05-29 | -2.99 |
| 2025-05-28 | -2.98 |
| 2025-05-27 | -2.81 |
| 2025-05-23 | -2.87 |
| 2025-05-22 | -2.87 |
| 2025-05-21 | -2.81 |
| 2025-05-20 | -2.87 |
| 2025-05-19 | -2.92 |
| 2025-05-16 | -3.07 |
| 2025-05-15 | -2.99 |
| 2025-05-14 | -2.85 |
| 2025-05-13 | -3.00 |
| 2025-05-12 | -3.07 |
| 2025-05-09 | -2.91 |
| 2025-05-08 | -3.14 |
| 2025-05-07 | -2.76 |
| 2025-05-06 | -2.76 |
| 2025-05-05 | -2.69 |
| 2025-05-02 | -2.94 |
| 2025-05-01 | -2.88 |
| 2025-04-30 | -2.91 |
| 2025-04-29 | -2.95 |
| 2025-04-28 | -3.04 |
| 2025-04-25 | -3.02 |
| 2025-04-24 | -3.10 |
| 2025-04-23 | -3.24 |
| 2025-04-22 | -2.94 |